Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 537.00
Bid: 534.00
Ask: 537.00
Change: 1.00 (0.19%)
Spread: 3.00 (0.562%)
Open: 535.00
High: 537.00
Low: 532.00
Prev. Close: 536.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of HIM Capital

15 Sep 2010 07:00

RNS Number : 6801S
Polar Capital Holdings PLC
15 September 2010
 



15 September 2010

 

Polar Capital Holdings plc

 

Polar Capital announces the acquisition of HIM Capital

 

Polar Capital Holdings plc ("Polar Capital" or the "Group") announces that it has exchanged contracts for the acquisition of HIM Capital Holdings Limited ("HIM"), a specialist fund manager with an established track record of managing financial funds, which has approximately $230 million of assets under management. The acquisition, which is expected to complete before the month end, will establish a strong financials sector franchise within the Group which is in line with Polar Capital's established growth strategy.

 

HIM's subsidiary, HIM Capital Limited ("HIM Capital"), was formerly called Hiscox Investment Management prior to the management buyout of the business from Hiscox plc at the end of 2007. HIM Capital has been managing financial funds since 1993 and currently has the following four open ended, long only funds invested in the financial sector: Hiscox Insurance Portfolio Fund, Hiscox Far Eastern Financial Fund, Hiscox European Financial Fund and HIM Income Fund. All four funds have significantly outperformed their benchmarks since launch.

 

The Hiscox Far Eastern Fund won the prestigious Lipper financials sector prize in the UK in 2010, while the Hiscox Insurance Portfolio Fund won the Lipper financials sector prize in Switzerland in 2009. Both of these funds are five star rated by Morningstar.

 

Commenting on the acquisition, Tim Woolley, Chief Executive of Polar Capital, said:

 

"We are absolutely delighted to be incorporating the HIM Capital team into the Group and establishing such a strong financials sector franchise for Polar Capital. The acquisition is in line with the Group's ambition to accelerate growth by attracting new investment talent and building sector specialist platforms from which we can develop the business and enhance returns to our shareholders. It is testament to the strength of our brand that we have been able to attract the HIM Capital team, which offers a unique group of highly experienced fund managers and a balanced portfolio of long-only funds with outstanding track records. We look forward to working with the team and capitalizing on Polar Capital's strong distribution network to unlock further value in these funds."

 

Alec Foster, Chairman of HIM Capital, added:

 

"This is an exciting opportunity for the HIM Capital team to continue building on the excellent track records of our funds. The combination with Polar Capital provides access to an established platform to broaden the shareholder base of our funds through their distribution network. We look forward to working with the Polar Capital team to achieve these goals."

 

 

-Ends-

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO) / John Mansell (CFO)

+44 (0)20 7227 2700

 

HIM Capital

Alec Foster (Chairman) / Mark Stacpoole (MD)

+44 (0)20 7929 5005

 

Numis Securities

Simon Blank (Nominated Adviser) / Charles Farquhar (Corporate Broking)

+44 (0)20 7260 1000

 

Financial Dynamics

Ed Gascoigne-Pees / Georgina Turner

+44 (0)20 7269 7132 / 20 7269 7136

 

 

Notes to editors

 

About Polar Capital

 

Polar Capital is a research driven investment management company providing a highly entrepreneurial environment for outstanding portfolio managers within a structure that offers a level of marketing, administrative and operational support normally found in much larger organisations.

 

Our objective is to achieve strong, sustainable earnings and dividend growth by building a highly diversified family of long-only, long-bias, equity long/short and other fundamentally driven hedge fund strategies managed under the Polar Capital brand.

 

Today Polar Capital has a staff of 55 of whom 28 are investment professionals managing 10 funds and seven managed accounts. These funds, which are aimed at institutional and professional investors, have combined assets under management as at 30 June 2010 $2.6 bn, $1.6 bn of which are within long only funds. Polar Capital has offices in London and Tokyo.

 

 

About HIM Capital

 

HIM Capital is a specialist fund manager with an established track record of managing financial funds. HIM Capital was formerly a subsidiary of Hiscox plc prior to the management buy-out of HIM Capital at the end of 2007. As part of Hiscox plc, HIM Capital was known as Hiscox Investment Management, an FSA regulated entity, which was formed in 1996. A new company, HIM Capital Holdings Limited, was formed for the purpose of the management buyout. HIM Capital's directors and staff together own 60% of the company with Hiscox plc owning 40%.

 

Hiscox Insurance Portfolio Fund AUM £63m at 31 Aug 2010 (launched in 1998)

The only European vehicle for investing in insurance industry companies on a global

basis. Managed by Alec Foster and Nick Martin

 

Hiscox Far Eastern Financial Fund AUM US$59m (£38m) at 31 Aug 2010 (launched in 1996)

The only European vehicle dedicated to investment in financial companies in Asia

excluding Japan. Managed by John Yakas

 

Hiscox European Financial Fund AUM €24m (£20m) at 31 Aug 2010 (launched in 1993)

Invests in European financial companies. Managed by John Yakas

 

HIM Income Fund AUM £27m at 31 Aug 2010 (launched in 2009)

Invests for income in financial companies worldwide. Managed by Nick Brind

 

Fund Performance

 

 

Performance since launch %

(to 31 Aug 2010)

 

Fund

Benchmark

Hiscox Insurance Portfolio Fund

+90.8%

+1.0%

Hiscox Far Eastern Financial Fund

+130.7%

+24.0%

Hiscox European Financial Fund

+232.8%

+106.2%

HIM Income Fund

+1.0%

-18.1%

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEZLFFBKFFBBQ
Date   Source Headline
10th Jan 201910:19 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSAUM Update
2nd Jan 20199:49 amRNSTotal Voting Rights
12th Dec 20184:00 pmRNSIssue of Equity
27th Nov 20184:40 pmRNSSecond Price Monitoring Extn
27th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018
11th Jun 201811:27 amRNSNet Asset Value(s)
1st Jun 20187:41 amRNSTotal Voting Rights
24th May 201810:59 amRNSDirector/PDMR Shareholding
24th May 20189:35 amRNSIssue of Equity
23rd May 201811:00 amRNSNotice of Results
23rd May 20189:37 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.